Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial
Contineum Therapeutics reported a Phase 2 failure in multiple sclerosis on Thursday afternoon, but most analysts don’t seem to view the miss as catastrophic. Contineum...
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page